Biotech (new drugs) stocks

바이오 신약

What are Biotech (new drugs) stocks in Korea?

The Biotech (new drugs) theme on jonbur groups 204 Korean stocks listed on KOSPI and KOSDAQ, worth ₩213T in total. On Oct 28, 2026 the group moved up 0.68% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.

Stocks: 204
Total market value: ₩213T
Day's move: +0.68%
As of: Oct 28, 2026
Largest members: Samsung Biologics, Celltrion, Alteogen

Earnings tracker · 3Q 2026

Reporting season · reports due by Nov 14

8 of 205 reportedOperating profit up vs a year ago: 5 of 6

Revenue+22.7%

Operating profit+52.3%

Net profitTurned to profit

Combined, for the companies that have reported, vs the same quarter a year ago

Company	Reported	Revenue	vs a year ago	Operating profit	vs a year ago	vs last quarter	Op. margin
Celltrion	Oct 12Preliminary	₩1.5T	+45.8%	₩510B	+69.2%	+12.9%	34.0%29.3%
Yuhan	Oct 28Preliminary	₩586B	+2.8%	₩35B	+57.8%	−48.0%	5.9%3.9%
Hanmi Pharm	Oct 27Preliminary	₩377B	+4.2%	₩38B	−31.3%	−71.2%	10.0%15.2%
ST Pharm	Oct 27Preliminary	₩98B	+19.1%	₩16B	+6.6%	−14.3%	16.1%18.0%
Bukwang Pharmaceutical IND	Oct 23Preliminary	₩58B	+21.2%	₩2.2B	+120.7%	+53.3%	3.7%2.0%
Dong-A ST	Oct 27Preliminary	₩207B	−4.4%	₩21B	+52.9%	+239.9%	10.4%6.5%
T&R Biofab	Oct 19Preliminary	₩8.9B	+28.1%	—	—	—	—
Shaperon	Oct 1Preliminary	₩4.7B	+2,683.4%	—	—	—	—
Samsung Biologics	Expected around Oct 28
Hanall Biopharma	Expected around Oct 29
Dong-A Pharmaceutical	Expected around Oct 29
Onconic Therapeutics	Expected around Oct 30
Bioneercorporation	Expected around Oct 31
Abion	Expected around Oct 31
SK Bioscience	Expected around Nov 3
GC Biopharma	Expected around Nov 3
Chong Kun Dang Pharmaceutical	Expected around Nov 3
JW Pharmaceutical	Expected around Nov 3
GC Cell	Expected around Nov 3
Hyundai Bioland	Expected around Nov 3
Choong ANG Vaccine Laboratory	Expected around Nov 3
Hugel	Expected around Nov 4
Protia	Expected around Nov 4
SK biopharmaceuticals	Expected around Nov 5
JW Lifescience	Expected around Nov 5
JW Shinyak	Expected around Nov 5
IL Dong Pharmaceutical	Expected around Nov 6
ISU Abxis	Expected around Nov 6
Cell Biotech	Expected around Nov 6
Seegene	Expected around Nov 7
Daewoong Pharma	Expected around Nov 7
NeoImmuneTech	Expected around Nov 7
QuadMedicine	Expected around Nov 7
Medy-Tox	Expected around Nov 10
AbClon	Expected around Nov 10
EuBiologics	Expected around Nov 10
Huons	Expected around Nov 10
Eye Gene	Expected around Nov 10
PharmaResearch	Expected around Nov 11
ABL Bio	Expected around Nov 11
Rznomics	Expected around Nov 11
Pharos iBio	Expected around Nov 11
Olipass	Expected around Nov 11
OSCOTECInc	Expected around Nov 12
MedPacto	Expected around Nov 12
Bio-Fd&C	Expected around Nov 12
CTC Bio	Expected around Nov 12
Gencurix	Expected around Nov 12
Chabiotech	Expected around Nov 13
G2GBIO	Expected around Nov 13
Pharmicell	Expected around Nov 13
HLB innoVation	Expected around Nov 13
Curocell	Expected around Nov 13
AprilBio	Expected around Nov 13
DuChemBio	Expected around Nov 13
3billion	Expected around Nov 13
Kangstem Biotech	Expected around Nov 13
Kukjeon	Expected around Nov 13
ViGenCell	Expected around Nov 13
Genexine	Expected around Nov 13
Aribiolab	Expected around Nov 13
DreamCIS	Expected around Nov 13
SunBio	Expected around Nov 13
Pangen Biotech	Expected around Nov 13
Cytogen	Expected around Nov 13
KoBioLabs	Expected around Nov 13
Aprogen Biologics	Expected around Nov 13
Wonbiogen	Expected around Nov 13
Eutilex	Expected around Nov 13
Biotoxtech	Expected around Nov 13
NGeneBio	Expected around Nov 13
Alteogen	Expected around Nov 14
HLB	Expected around Nov 14
LigaChem Biosciences	Expected around Nov 14
Peptron	Expected around Nov 14
Voronoi	Expected around Nov 14
OliX Pharmaceuticals	Expected around Nov 14
D&D Pharmatech	Expected around Nov 14
Caregen	Expected around Nov 14
Mezzion Pharma	Expected around Nov 14
Naturecell	Expected around Nov 14
Kolon TissueGene	Expected around Nov 14
Curiox Biosystems	Expected around Nov 14
Daewoong	Expected around Nov 14
Qurient	Expected around Nov 14
Proteina	Expected around Nov 14
Hyundai Bioscience	Expected around Nov 14
GI Innovation	Expected around Nov 14
Shinpoong Pharmaceutical	Expected around Nov 14
GC	Expected around Nov 14
Penetrium Bioscience	Expected around Nov 14
GemVax & KAEL	Expected around Nov 14
HLB Life Science	Expected around Nov 14
Orum Therapeutics	Expected around Nov 14
Medipostco	Expected around Nov 14
SillaJen	Expected around Nov 14
ToolGen	Expected around Nov 14
NKGen Biotech Korea	Expected around Nov 14
ImmuneOncia Therapeutics	Expected around Nov 14
Genomictree	Expected around Nov 14
S.Biomedics	Expected around Nov 14
FutureChem	Expected around Nov 14
HLB Therapeutics	Expected around Nov 14
IntoCell	Expected around Nov 14
BioPlus	Expected around Nov 14
Genome&Company	Expected around Nov 14
GC Genome	Expected around Nov 14
Binex	Expected around Nov 14
curacle	Expected around Nov 14
Helixmith	Expected around Nov 14
Kolon Life Science	Expected around Nov 14
Eone Diagnomics Genome Center	Expected around Nov 14
Aptabio Therapeutics	Expected around Nov 14
Cellbion	Expected around Nov 14
Bio Solution	Expected around Nov 14
Y-Biologics	Expected around Nov 14
Aribio Holdings	Expected around Nov 14
Anterogen	Expected around Nov 14
Macrogen	Expected around Nov 14
TiumBio	Expected around Nov 14
Keeps Biopharma	Expected around Nov 14
Celemics	Expected around Nov 14
HLB bioStep	Expected around Nov 14
Asta	Expected around Nov 14
Metabiomed	Expected around Nov 14
iNtRON Biotechnology	Expected around Nov 14
Vaxcell-Bio Therapeutics	Expected around Nov 14
Corestemchemon	Expected around Nov 14
Aminologics	Expected around Nov 14
Cellumed	Expected around Nov 14
Enzychem Lifesciences	Expected around Nov 14
HLB Genex	Expected around Nov 14
Polaris AI Pharma	Expected around Nov 14
SCL Science	Expected around Nov 14
Choolip & Sciences	Expected around Nov 14
Sugentech	Expected around Nov 14
Naturalendo Tech	Expected around Nov 14
Amicogen	Expected around Nov 14
Optipharm	Expected around Nov 14
PharmGen Science	Expected around Nov 14
Cellid	Expected around Nov 14
Tego Science	Expected around Nov 14
Adbiotech	Expected around Nov 14
HLB Panagene	Expected around Nov 14
Psomagen	Expected around Nov 14
ENCell	Expected around Nov 14
Geninus	Expected around Nov 14
Aprogen	Expected around Nov 14
BL Pharmtech	Expected around Nov 14
GeneOne Life Science	Expected around Nov 14
CJ Bioscience	Expected around Nov 14
RPbio	Expected around Nov 14
Quratis	Expected around Nov 14
Gene Bio Tech	Expected around Nov 14
Oncocross	Expected around Nov 14
HLB Pep	Expected around Nov 14
Organoidsciences	Expected around Nov 14
Orientbio	Expected around Nov 14
Kolmar BioTech	Expected around Nov 14
Kainos Medicine	Expected around Nov 14
IMBdx	Expected around Nov 14
Genolution	Expected around Nov 14
SLSBio(Specialty Lab Solution Bio)	Expected around Nov 14
Genematrix	Expected around Nov 14
Synteka Bio	Expected around Nov 14
C&R Research	Expected around Nov 14
GFC Life Science	Expected around Nov 14
Enbioco	Expected around Nov 14
WooGene B&Gco	Expected around Nov 14
Xcell Therapeutics	Expected around Nov 14
PeopleBio	Expected around Nov 14
Celestra	Expected around Nov 14
From Bio	Expected around Nov 14
BioInfra	Expected around Nov 14
208340	Expected around Nov 14
Phionx	Expected around Nov 27
Prestige BioPharma	Expected around Nov 28
Inventage Lab	Expected around Dec 1
Hans Biomed	Expected around Dec 18
Aimed Bio	Not yet
Ingenia Therapeutics	Not yet
Samyang Biopharm	Not yet
IMBiologics	Not yet
Kanaph Therapeutics	Not yet
Ensol Biosciences	Not yet
Inventera	Not yet
Imgt	Not yet
HL Genomics	Not yet
Epi Biotech	Not yet
NovMetaPharma	Not yet
ProGen	Not yet
Plumbline Life Sciences	Not yet
Moogene Medi	Not yet
Curachem	Not yet
Invites Biocore	Not yet
Median Diagnostics	Not yet
AngioLab	Not yet
Medizen Humancare	Not yet
Cronex	Not yet
OceansBio	Not yet
BioInfra Life Science	Not yet
283100	Not yet
258540	Not yet
072520	Not yet
341170	Not yet

Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.

Technical breadth

After the close on Oct 28, 2026

Above 20-day average: 13.9%
Above 60-day average: 23.1%
RSI above 70: 0.6%
RSI below 30: 5.2%
52-week highs: 0
52-week lows: 8

Index gauge · Short term

Bearish

0 bullish, 2 neutral, 7 bearish

Index gauge · Medium term

Bearish

0 bullish, 1 neutral, 7 bearish

Technical read

The Biotech (new drugs) theme covers 173 members, and only 13.9% of them trade above their 20-day averages while 23.1% sit above their 60-day averages. Eight members hit 52-week lows and none reached 52-week highs, with 5.2% of members showing RSI readings at the low extreme and 0.6% at the high extreme. The equal-weighted index gauge reads bearish on both short-term (7 bearish signals against 0 bullish) and medium-term (7 bearish, 0 bullish) measures, with RSI at 39.4 and the index positioned below its cloud.

Written by AI from the indicator values above. Not advice.

Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Credit & macro

MaturitiesOct 29, 202675Hyundai Department Store: ₩200bn of bonds due in the next 6 months vs ₩158bn cash₩200bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Hyundai Department Store Daewonkangup Hyundai G.F. Holdings Zinus Handsome Samwonsteel
MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK Reit SK hynix SK Networks SK Discovery SKC SK Telecom

ETFs for this theme

All ETFs →

AUM · Flow 1w

Creators talking about this

Doctors begin to prescribe country’s first domestically developed obesity drug on Thurs.Arirang News · via YouTube

Biotech (new drugs)

−4.73%

바이오 신약

The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.

204 companies · 50 up · 18 flat · 136 down

Traded value: ₩698B
Value vs 20-day average: 0.77×
Top gainer: HLB bioStep
Largest company: Samsung Biologics

Companies in this theme

Market cap Value traded Gainers Losers NPS stake

All KOSPI KOSDAQ

NPS owns > 5%

Company	Price	Monthly	Traded value	Market cap	NPS
Samsung Biologics207940 · KOSPI	₩1,372,000	+0.44%	₩69B	₩64T	6.88%
Celltrion068270 · KOSPI	₩189,800	+6.99%	₩80B	₩44T	7.28%
Alteogen196170 · KOSDAQ	₩223,000	−10.80%	₩53B	₩16T	2.68%
SK biopharmaceuticals326030 · KOSPI	₩75,200	−0.92%	₩8.9B	₩5.9T	6.00%
Yuhan000100 · KOSPI	₩77,300	+4.32%	₩27B	₩5.7T	6.83%
HLB028300 · KOSDAQ	₩40,650	+33.06%	₩19B	₩5.4T	1.16%
Hanmi Pharm128940 · KOSPI	₩369,500	−28.94%	₩42B	₩4.7T	9.61%
SK Bioscience302440 · KOSPI	₩32,150	−10.07%	₩2.2B	₩2.5T	5.50%
LigaChem Biosciences141080 · KOSDAQ	₩66,200	−18.07%	₩13B	₩2.5T	4.99%
PharmaResearch214450 · KOSDAQ	₩228,500	−29.15%	₩44B	₩2.4T	7.14%
ABL Bio298380 · KOSDAQ	₩41,800	−17.72%	₩13B	₩2.3T	4.02%
Hugel145020 · KOSDAQ	₩181,500	−2.94%	₩4.8B	₩2.3T	2.29%
Peptron087010 · KOSDAQ	₩97,200	−33.20%	₩16B	₩2.3T	1.63%
Voronoi310210 · KOSDAQ	₩121,100	−17.79%	₩7.9B	₩2.3T	2.78%
OliX Pharmaceuticals226950 · KOSDAQ	₩97,300	−5.26%	₩22B	₩2.2T	5.04%
Hanall Biopharma009420 · KOSPI	₩38,500	−17.38%	₩7.1B	₩2T	10.56%
D&D Pharmatech347850 · KOSDAQ	₩42,900	−3.60%	₩28B	₩2T	1.75%
Caregen214370 · KOSDAQ	₩34,350	−14.55%	₩1.9B	₩1.8T	0.65%
Mezzion Pharma140410 · KOSDAQ	₩52,600	−36.01%	₩8.6B	₩1.6T	0.50%
ST Pharm237690 · KOSDAQ	₩77,200	−15.44%	₩29B	₩1.6T	5.77%
Seegene096530 · KOSDAQ	₩33,500	−1.47%	₩8.8B	₩1.6T	0.64%
GC Biopharma006280 · KOSPI	₩130,500	+5.84%	₩1.7B	₩1.5T	6.68%
Naturecell007390 · KOSDAQ	₩22,150	−10.14%	₩3.6B	₩1.4T	0.44%
OSCOTECInc039200 · KOSDAQ	₩36,650	+2.37%	₩3.1B	₩1.4T	3.87%
Aimed Bio0009K0 · KOSDAQ	₩20,850	−2.57%	₩2.4B	₩1.4T	0.03%
Kolon TissueGene950160 · KOSDAQ	₩14,600	−7.59%	₩4.9B	₩1.2T	0.57%
Ingenia Therapeutics950260 · KOSDAQ	₩23,600	−3.28%	₩5.8B	₩1.2T	—
Daewoong Pharma069620 · KOSPI	₩99,900	−5.93%	₩2.5B	₩1.2T	10.30%
Curiox Biosystems445680 · KOSDAQ	₩62,400	+25.81%	₩7.3B	₩1.1T	1.25%
Daewoong003090 · KOSPI	₩14,800	−6.86%	₩1.4B	₩861B	3.25%
Chong Kun Dang Pharmaceutical185750 · KOSPI	₩61,900	−4.62%	₩716M	₩854B	6.34%
Qurient115180 · KOSDAQ	₩17,970	−16.60%	₩2.6B	₩674B	3.88%
Chabiotech085660 · KOSDAQ	₩7,080	−11.06%	₩1.2B	₩658B	0.31%
Rznomics476830 · KOSDAQ	₩23,400	−8.41%	₩4B	₩656B	3.96%
G2GBIO456160 · KOSDAQ	₩37,900	+18.25%	₩26B	₩630B	2.41%
Pharmicell005690 · KOSPI	₩10,230	−18.42%	₩4.3B	₩614B	2.38%
Onconic Therapeutics476060 · KOSDAQ	₩13,070	−13.62%	₩1.2B	₩593B	—
Dong-A Pharmaceutical000640 · KOSPI	₩87,600	−5.40%	₩825M	₩590B	9.45%
Proteina468530 · KOSDAQ	₩51,500	+8.99%	₩10B	₩572B	3.78%
JW Pharmaceutical001060 · KOSPI	₩23,200	−13.59%	₩975M	₩570B	2.44%
Hyundai Bioscience048410 · KOSDAQ	₩5,870	−14.31%	₩7.4B	₩566B	0.37%
HLB innoVation024850 · KOSDAQ	₩14,900	−1.59%	₩1.5B	₩515B	—
Medy-Tox086900 · KOSDAQ	₩65,800	−2.37%	₩903M	₩480B	1.44%
GI Innovation358570 · KOSDAQ	₩7,140	−19.50%	₩1.3B	₩461B	4.07%
Shinpoong Pharmaceutical019170 · KOSPI	₩8,460	−8.54%	₩1.4B	₩443B	0.39%
GC005250 · KOSPI	₩9,130	−3.28%	₩384M	₩429B	5.94%
Penetrium Bioscience187660 · KOSDAQ	₩6,660	+0.45%	₩5.6B	₩426B	—
AbClon174900 · KOSDAQ	₩21,100	+7.65%	₩5.5B	₩421B	3.57%
GemVax & KAEL082270 · KOSDAQ	₩9,040	−15.36%	₩1.1B	₩411B	2.55%
HLB Life Science067630 · KOSDAQ	₩3,340	+27.48%	₩481M	₩407B	0.07%
IL Dong Pharmaceutical249420 · KOSPI	₩12,790	−7.59%	₩1.2B	₩405B	2.30%
Curocell372320 · KOSDAQ	₩25,000	+17.92%	₩1.1B	₩381B	0.46%
Bukwang Pharmaceutical IND003000 · KOSPI	₩3,750	−4.58%	₩818M	₩370B	0.68%
Orum Therapeutics475830 · KOSDAQ	₩16,360	−34.56%	₩1.5B	₩356B	0.09%
AprilBio397030 · KOSDAQ	₩12,400	−31.53%	₩1.3B	₩342B	0.95%
Medipostco078160 · KOSDAQ	₩8,670	−3.34%	₩803M	₩340B	1.55%
Dong-A ST170900 · KOSPI	₩34,900	+1.31%	₩337M	₩340B	4.78%
Inventage Lab389470 · KOSDAQ	₩23,950	−2.24%	₩1.8B	₩319B	0.31%
Samyang Biopharm0120G0 · KOSPI	₩41,550	−10.65%	₩1.1B	₩309B	1.73%
SillaJen215600 · KOSDAQ	₩2,120	−5.36%	₩1.1B	₩294B	0.09%
ToolGen199800 · KOSDAQ	₩29,800	−11.70%	₩854M	₩291B	0.43%
EuBiologics206650 · KOSDAQ	₩7,620	−7.52%	₩551M	₩277B	0.17%
NKGen Biotech Korea182400 · KOSDAQ	₩3,670	0.00%	₩0	₩265B	—
ImmuneOncia Therapeutics424870 · KOSDAQ	₩2,870	−6.82%	₩1.1B	₩262B	—
Genomictree228760 · KOSDAQ	₩10,400	−5.45%	₩641M	₩259B	0.51%
Hans Biomed042520 · KOSDAQ	₩17,880	+0.56%	₩1.4B	₩255B	4.88%
Prestige BioPharma950210 · KOSPI	₩4,220	−29.31%	₩3B	₩254B	0.15%
S.Biomedics304360 · KOSDAQ	₩20,150	0.00%	₩792M	₩251B	—
FutureChem220100 · KOSDAQ	₩8,080	+29.70%	₩2.6B	₩250B	0.76%
HLB Therapeutics115450 · KOSDAQ	₩2,635	+32.61%	₩917M	₩249B	0.10%
IntoCell287840 · KOSDAQ	₩16,300	−6.75%	₩351M	₩245B	1.04%
IMBiologics493280 · KOSDAQ	₩14,230	−19.47%	₩927M	₩211B	—
Huons243070 · KOSDAQ	₩17,330	−7.97%	₩286M	₩208B	0.71%
BioPlus099430 · KOSDAQ	₩3,360	+2.28%	₩275M	₩207B	0.42%
DuChemBio176750 · KOSDAQ	₩7,160	+14.19%	₩2.2B	₩204B	0.04%
Genome&Company314130 · KOSDAQ	₩3,840	−20.58%	₩1B	₩201B	0.24%
GC Genome340450 · KOSDAQ	₩8,440	+3.18%	₩6.7B	₩200B	—
Binex053030 · KOSDAQ	₩6,100	+0.66%	₩379M	₩199B	2.17%
3billion394800 · KOSDAQ	₩6,200	+6.90%	₩6.7B	₩197B	4.02%
Bioneercorporation064550 · KOSDAQ	₩7,070	−13.57%	₩1.1B	₩182B	0.10%
curacle365270 · KOSDAQ	₩8,210	−14.21%	₩294M	₩182B	0.50%
Kangstem Biotech217730 · KOSDAQ	₩1,863	−9.56%	₩387M	₩175B	0.10%
Helixmith084990 · KOSDAQ	₩3,730	+24.54%	₩938M	₩172B	0.12%
Kolon Life Science102940 · KOSDAQ	₩12,940	−7.04%	₩608M	₩169B	0.50%
Eone Diagnomics Genome Center245620 · KOSDAQ	₩741	0.00%	₩0	₩167B	—
JW Lifescience234080 · KOSPI	₩10,510	−4.28%	₩107M	₩166B	0.72%
GC Cell144510 · KOSDAQ	₩10,470	−25.48%	₩3.7B	₩165B	0.06%
Aptabio Therapeutics293780 · KOSDAQ	₩5,490	−15.02%	₩920M	₩154B	0.05%
Cellbion308430 · KOSDAQ	₩11,940	−18.78%	₩281M	₩154B	—
ISU Abxis086890 · KOSDAQ	₩3,595	+1.99%	₩232M	₩147B	0.20%
Bio Solution086820 · KOSDAQ	₩5,590	−12.52%	₩322M	₩145B	0.15%
Y-Biologics338840 · KOSDAQ	₩9,390	+12.59%	₩890M	₩145B	0.17%
Aribio Holdings290690 · KOSDAQ	₩2,700	−32.16%	₩650M	₩143B	—
Anterogen065660 · KOSDAQ	₩13,960	−5.03%	₩248M	₩140B	0.30%
Cell Biotech049960 · KOSDAQ	₩14,830	−0.60%	₩53M	₩139B	0.00%
Kanaph Therapeutics0082N0 · KOSDAQ	₩10,030	−16.28%	₩866M	₩133B	—
JW Shinyak067290 · KOSDAQ	₩2,375	−24.36%	₩2.7B	₩133B	—
Ensol Biosciences140610 · KONEX	₩8,920	−11.94%	₩27M	₩128B	—
Hyundai Bioland052260 · KOSDAQ	₩4,260	+6.90%	₩526M	₩128B	0.00%
Macrogen038290 · KOSDAQ	₩11,240	−7.03%	₩103M	₩122B	4.56%
TiumBio321550 · KOSDAQ	₩3,835	−13.63%	₩729M	₩115B	0.31%
Kukjeon307750 · KOSDAQ	₩2,120	−5.78%	₩1.3B	₩114B	—
Keeps Biopharma256940 · KOSDAQ	₩5,510	−9.23%	₩83M	₩111B	—
ViGenCell308080 · KOSDAQ	₩5,040	−11.89%	₩512M	₩103B	0.59%
Celemics331920 · KOSDAQ	₩9,230	−18.68%	₩99M	₩103B	—
HLB bioStep278650 · KOSDAQ	₩5,910	+136.40%	₩2.5B	₩103B	—
Genexine095700 · KOSDAQ	₩2,250	−17.73%	₩437M	₩102B	0.15%
MedPacto235980 · KOSDAQ	₩2,925	+4.28%	₩254M	₩100B	2.96%
Asta246720 · KOSDAQ	₩6,070	0.00%	₩0	₩99B	—
Metabiomed059210 · KOSDAQ	₩3,635	+0.14%	₩624M	₩99B	—
Aribiolab261780 · KOSDAQ	₩3,405	−3.13%	₩629M	₩99B	—
DreamCIS223250 · KOSDAQ	₩3,870	+17.63%	₩960M	₩95B	—
iNtRON Biotechnology048530 · KOSDAQ	₩3,045	+8.17%	₩437M	₩94B	1.38%
Vaxcell-Bio Therapeutics323990 · KOSDAQ	₩3,955	−6.06%	₩495M	₩92B	0.07%
T&R Biofab246710 · KOSDAQ	₩1,906	−16.77%	₩189M	₩91B	0.95%
Corestemchemon166480 · KOSDAQ	₩1,705	−19.76%	₩236M	₩90B	0.02%
Aminologics074430 · KOSDAQ	₩1,007	−5.62%	₩76M	₩90B	—
Cellumed049180 · KOSDAQ	₩1,009	0.00%	₩0	₩84B	—
Enzychem Lifesciences183490 · KOSDAQ	₩990	0.00%	₩0	₩84B	0.30%
Choong ANG Vaccine Laboratory072020 · KOSDAQ	₩8,830	−3.50%	₩32M	₩82B	—
Bio-Fd&C251120 · KOSDAQ	₩9,280	+1.20%	₩66M	₩81B	0.59%
Pharos iBio388870 · KOSDAQ	₩5,890	+7.09%	₩126M	₩76B	—
HLB Genex187420 · KOSDAQ	₩2,300	+28.71%	₩260M	₩75B	—
Polaris AI Pharma041910 · KOSDAQ	₩5,640	+4.64%	₩145M	₩75B	—
Yuhan Pref.000105 · KOSPI	₩65,200	−1.36%	₩66M	₩75B	—
SCL Science246960 · KOSDAQ	₩2,135	−21.51%	₩634M	₩74B	—
Eye Gene185490 · KOSDAQ	₩1,717	−11.95%	₩339M	₩74B	2.40%
Choolip & Sciences291650 · KOSDAQ	₩2,310	+25.27%	₩91M	₩71B	—
Inventera0007J0 · KOSDAQ	₩8,830	−37.82%	₩339M	₩69B	—
SunBio067370 · KOSDAQ	₩5,680	+0.71%	₩17M	₩69B	—
Sugentech253840 · KOSDAQ	₩4,105	−10.08%	₩150M	₩69B	—
Naturalendo Tech168330 · KOSDAQ	₩2,095	−11.42%	₩8.7M	₩67B	0.10%
CTC Bio060590 · KOSDAQ	₩2,685	−10.65%	₩85M	₩65B	—
Amicogen092040 · KOSDAQ	₩915	−2.14%	₩244M	₩65B	0.37%
Optipharm153710 · KOSDAQ	₩4,375	−4.37%	₩70M	₩64B	0.44%
Pangen Biotech222110 · KOSDAQ	₩4,640	−3.43%	₩24M	₩63B	—
PharmGen Science004720 · KOSPI	₩2,740	−3.01%	₩91M	₩62B	0.08%
Abion203400 · KOSDAQ	₩3,380	0.00%	₩0	₩61B	0.98%
Cellid299660 · KOSDAQ	₩2,040	−22.14%	₩651M	₩60B	0.02%
Tego Science191420 · KOSDAQ	₩7,400	+2.92%	₩57M	₩60B	—
Adbiotech179530 · KOSDAQ	₩1,909	+8.84%	₩89M	₩59B	—
HLB Panagene046210 · KOSDAQ	₩1,300	+17.97%	₩158M	₩59B	—
NeoImmuneTech950220 · KOSDAQ	₩1,677	−11.08%	₩209M	₩57B	—
Cytogen217330 · KOSDAQ	₩2,475	−18.18%	₩138M	₩57B	—
Psomagen950200 · KOSDAQ	₩2,965	−4.82%	₩1.5B	₩57B	—
Imgt456570 · KONEX	₩10,630	−20.02%	₩16M	₩56B	—
HL Genomics0156T0 · KOSDAQ	₩7,150	−14.58%	₩225M	₩56B	—
ENCell456070 · KOSDAQ	₩5,030	−15.03%	₩5.2B	₩55B	—
KoBioLabs348150 · KOSDAQ	₩2,720	+2.06%	₩31M	₩53B	—
Geninus389030 · KOSDAQ	₩1,305	−32.70%	₩651M	₩51B	—
QuadMedicine464490 · KOSDAQ	₩4,365	−1.80%	₩352M	₩50B	—
Aprogen007460 · KOSPI	₩1,940	−3.48%	₩746M	₩50B	0.76%
BL Pharmtech065170 · KOSDAQ	₩1,767	−26.22%	₩810M	₩49B	—
GeneOne Life Science011000 · KOSPI	₩2,670	0.00%	₩0	₩49B	0.19%
Epi Biotech446440 · KONEX	₩21,000	+23.53%	₩231,000	₩48B	—
CJ Bioscience311690 · KOSDAQ	₩3,650	−1.62%	₩9.2M	₩48B	—
Protia303360 · KOSDAQ	₩3,640	+1.82%	₩22M	₩47B	—
RPbio314140 · KOSDAQ	₩5,300	−10.92%	₩18M	₩46B	—
Gencurix229000 · KOSDAQ	₩1,957	0.00%	₩0	₩46B	0.81%
NovMetaPharma229500 · KONEX	₩3,455	−34.69%	₩81M	₩45B	—
Quratis348080 · KOSDAQ	₩3,495	−14.86%	₩56M	₩45B	—
Gene Bio Tech086060 · KOSDAQ	₩5,140	+7.87%	₩78M	₩44B	—
Aprogen Biologics003060 · KOSPI	₩1,394	−14.95%	₩114M	₩42B	0.08%
Oncocross382150 · KOSDAQ	₩3,145	−13.36%	₩64M	₩41B	—
Wonbiogen307280 · KOSDAQ	₩5,760	−3.52%	₩163M	₩41B	—
HLB Pep196300 · KOSDAQ	₩4,100	−4.65%	₩44M	₩39B	—
Organoidsciences476040 · KOSDAQ	₩5,900	−12.85%	₩65M	₩39B	1.38%
Orientbio002630 · KOSPI	₩1,288	−29.58%	₩30M	₩38B	0.06%
Kolmar BioTech215380 · KOSDAQ	₩2,140	−6.35%	₩90M	₩36B	—
Kainos Medicine284620 · KOSDAQ	₩1,087	0.00%	₩0	₩36B	—
IMBdx461030 · KOSDAQ	₩2,475	−9.84%	₩35M	₩35B	0.31%
Eutilex263050 · KOSDAQ	₩959	0.00%	₩0	₩35B	0.74%
Biotoxtech086040 · KOSDAQ	₩2,110	−5.80%	₩19M	₩34B	—
Genolution225220 · KOSDAQ	₩1,717	+19.40%	₩61M	₩33B	—
ProGen296160 · KONEX	₩2,100	−13.93%	₩1.9M	₩32B	—
SLSBio(Specialty Lab Solution Bio)246250 · KOSDAQ	₩1,969	0.00%	₩0	₩30B	—
Genematrix109820 · KOSDAQ	₩1,432	−9.77%	₩26M	₩29B	—
Synteka Bio226330 · KOSDAQ	₩1,074	−16.68%	₩131M	₩26B	0.18%
C&R Research359090 · KOSDAQ	₩2,205	−5.57%	₩16M	₩25B	—
GFC Life Science388610 · KOSDAQ	₩4,480	−20.57%	₩211M	₩24B	—
Shaperon378800 · KOSDAQ	₩2,350	−7.84%	₩38M	₩22B	—
Enbioco352940 · KOSDAQ	₩1,901	−11.99%	₩9.9M	₩21B	—
WooGene B&Gco018620 · KOSDAQ	₩2,770	+0.73%	₩74M	₩19B	—
Plumbline Life Sciences222670 · KONEX	₩4,635	0.00%	₩0	₩19B	—
Moogene Medi322970 · KONEX	₩1,810	−4.64%	₩267,125	₩18B	—
Xcell Therapeutics373110 · KOSDAQ	₩1,040	+4.10%	₩47M	₩18B	—
GC 2nd Pref.005257 · KOSPI	₩16,450	−11.99%	₩1.5M	₩14B	—
PeopleBio304840 · KOSDAQ	₩561	0.00%	₩0	₩14B	—
Celestra352770 · KOSDAQ	₩5,250	0.00%	₩0	₩14B	—
Olipass244460 · KOSDAQ	₩1,651	0.00%	₩0	₩13B	—
Curachem456190 · KONEX	₩7,210	0.00%	₩0	₩13B	—
From Bio377220 · KOSDAQ	₩1,909	−23.18%	₩171M	₩11B	—
NGeneBio354200 · KOSDAQ	₩665	−47.80%	₩278M	₩11B	—
Invites Biocore216400 · KONEX	₩1,360	−6.14%	₩167,554	₩10B	—
JW Pharmaceutical 2nd Pref.001067 · KOSPI	₩49,600	−1.20%	₩347,200	₩10B	—
Median Diagnostics233250 · KONEX	₩4,800	0.00%	₩0	₩8.4B	—
BioInfra199730 · KOSDAQ	₩1,640	+111.61%	₩166M	₩8B	—
AngioLab251280 · KONEX	₩2,170	−11.97%	₩9.1M	₩7.9B	—
JW Pharmaceutical Pref.001065 · KOSPI	₩21,200	−4.72%	₩233,250	₩7.2B	—
Phionx900100 · KOSDAQ	₩1,155	+10.95%	₩88M	₩6.1B	—
Medizen Humancare236340 · KONEX	₩1,350	−32.47%	₩191,200	₩4.1B	—
Cronex215570 · KONEX	₩600	+8.30%	₩634,595	₩4B	—
OceansBio332190 · KONEX	₩2,195	−12.72%	₩4,700	₩3.2B	—
BioInfra Life Science266470 · KONEX	₩99	−1.00%	₩180,195	₩2.8B	—

Source: KRX statistical information